The global artificial urinary sphincter market is anticipated to be valued at US$ 459.8 million in 2023 and is anticipated to expand at a CAGR of 5.2%. It is predicted to be worth US$ 760.5 million in 2033. Growth is attributed to the increasing use of lactic acid in end-user industries. A CAGR of 3.3% was registered for the market from 2018 to 2022.
Urinary sphincters are two muscles that control the passage of urine in the urinary bladder through the urethra. These muscles play a vital role in the retention and release of urine. These two muscles are the external urethral sphincter and the internal urethral sphincter. When one of the muscles contracts, the urethra is shut and hence the passage of urine is stopped.
An artificial urinary sphincter (AUS) is a device which is composed of silicone rubber that is preferred for the treatment of urinary incontinence. The urinary sphincter is a muscle that controls the flow of urine through your bladder. (AUS) is used to control the flow of urine and is most commonly used in men. It is designed to supplement the function of the natural urinary sphincter which restricts the urine flow out of the bladder.
An artificial urinary sphincter is an implantable, fluid-filled, solid silicone elastomer device. It is a standard treatment for male stress urinary incontinence. It is preferred as it provides discrete bladder control
| Attribute | Artificial Urinary Sphincter Market (From 2018 to 2022) |
|---|---|
| CAGR | 3.3% |
| Market Size - 2018 | US$ 375.3 million |
| Market Size - 2022 | US$ 441.7 million |
| Attribute | Artificial Urinary Sphincter Market (From 2023 to 2033) |
|---|---|
| CAGR | 5.2% |
| Market Size - 2023 | US$ 459.8 million |
| Market Size - 2033 | US$ 760.5 million |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
The artificial urinary sphincter (AUS) market witnessed significant growth between 2018 and 2022, driven by rising cases of urinary incontinence and the increasing adoption of minimally invasive surgical procedures. Additionally, technological advancements and product innovations further propelled market expansion.
From 2023 to 2033, the AUS market is anticipated to experience significant growth. Factors such as the aging population, growing awareness about urinary incontinence treatment options, and continuous advancements in healthcare technology are expected to accelerate market demand. Further, emerging economies and developing healthcare infrastructure may contribute to the market's expansion, making AUS a key focus area for medical device manufacturers and healthcare providers.
The AUS market is primarily driven by a few key factors such as the heavy reliance of patients on time-tested products and the increasing advancements in the artificial urinary sphincter, new product launches, and preference for safe and effective solutions by the patient group. In addition to this, the market observes significant growth due to increasing healthcare expenditure in developing countries.
The artificial urinary sphincter market is driven by the increasing incidence of urinary incontinence and the growth in the geriatric population across the globe. Moreover, the increasing number of prostate surgeries in men also leads to urinary incontinence resulting in one of the growth factors for the AUS market.
Principal Consultant
Numerous obstacles are likely to pose a challenge to market growth, although the artificial urinary sphincter (AUS) market has numerous end-uses. The main factor affecting the growth of the artificial urinary sphincter market is the high treatment costs of the artificial urinary sphincter which limit the usage of the artificial urinary sphincter in the healthcare industry.
The artificial urinary sphincter market is also associated with many risks regarding an injury to the urethra or bladder during the placement of the device which restricts the adoption among patients, device infection or persistent stress, and other side effects due to infections.
Recurrent cases of device failure have resulted in the loss of market share for manufacturers. Also, the factors such as stringent government regulations and the dearth of skilled professionals are expected to restrain market growth.
| Category | End User |
|---|---|
| Leading Segment | Hospitals |
| Market Share | 66.30% |
| Category | Gender |
|---|---|
| Leading Segment | Male |
| Market Share | 78.20% |
The global market has been categorized into hospitals, clinics, and Ambulatory Surgery Centers (ASCs) based on end-use. In 2022, the hospitals segment captured a significant share of the revenue. This can be attributed to the growing prevalence of urine incontinence and the increasing adoption of innovative treatment options. Further, the rise in hospital admissions for urine incontinence is a key driver of revenue growth in this segment.
Hospitals offer a wide range of treatment options, including surgical procedures, which contributes to the high demand for artificial urinary sphincters. Additionally, the presence of advanced medical facilities and access to skilled healthcare professionals are expected to boost revenue growth in the hospitals segment.
The clinics segment is projected to exhibit significant revenue growth during the forecast period. This growth is driven by the escalating prevalence of urine incontinence among the elderly population and the growing demand for minimally invasive treatment alternatives.
Patients often opt for outpatient procedures at clinics due to their affordability compared to hospitals. The clinics' accessibility to innovative diagnostic and therapeutic tools is expected to contribute to revenue growth.
The ASCs segment is anticipated to experience significantly notable revenue growth during the forecast period. This growth is primarily fueled by the increasing demand for same-day operations and the preference for outpatient procedures.
ASCs offer patients access to high-quality care in a comfortable environment, serving as a convenient alternative to hospitals and clinics. ASCs further provide cost-effective treatment options, which is expected to drive revenue growth in this segment.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
| Countries | Market Share (2023) |
|---|---|
| North America | 34.8% |
| Europe | 25.8% |
North America was the significantly growing region for the artificial urinary sphincter industry. The trend is expected to continue into the forecast period owing to the development of many treatment facilities and rising investments in the healthcare sector. Moreover, North America is anticipated to account for a market share of 35% owing to an increase in the use of urinary incontinence devices by patients.
Factors such as an increase in the geriatric population, the presence of research & development programs, and high-class healthcare infrastructure are boosting demand in the urinary cystitis management market.
The market in North America is anticipated to be driven by an increasing number of market players researching urine incontinence, increasing awareness about the availability of surgical treatment for urological disorders, and the growing importance of surgical management of stress urinary incontinence.
The adoption of new approaches for sphincter placement has paved the way for new dimensions for surgical procedures. This is expected to boost the growth of the market.
| Countries | Market CAGR (From 2023 to 2033) |
|---|---|
| China | 6.3% |
| India | 5.2% |
| Australia | 4.6% |
| United Kingdom | 3.6% |
According to Future Market Insights, Europe accounts for a 26% share of the total global artificial urinary sphincter industry. The growth in Europe is attributed to growing allied industries in the region. An increase in government investments in the healthcare sector in emerging markets is expected to offer new opportunities during the analysis period.
The United Kingdom is predicted to make the most significant contribution to developing the regional market. This can be attributed to the presence of resources, the contribution of key players, and the ongoing development of the healthcare sector.
The factors which might fuel the growth of the artificial urinary sphincter market in the Asia Pacific are rising healthcare infrastructure and rapid development of the healthcare infrastructure across Asian countries. Further, the expansion of the regional market can be attributed to the increasing disposable income among developing countries such as India, China, and Japan.
There is an increase in the geriatric population and a growing number of healthcare centers such as hospitals offering treatment of urological conditions in the region. According to the Continence Foundation of Australia, nearly 5 million people in Australia experience bladder or bowel control problems. An increase in the number of urology care centers with technologically advanced surgical devices fuels the growth of the global artificial urinary sphincter market.
| Countries | Market Share - 2023 |
|---|---|
| The United States | 31.1% |
| Germany | 6.3% |
| Japan | 4.9% |
The competition in the artificial urinary sphincter (AUS) market is characterized by a moderate level of competition. Several key artificial urinary sphincter manufacturers dominate the market, including medical device manufacturers and healthcare companies. Further, these companies continually invest in research and development activities to improve their product offerings and gain a competitive edge.
The artificial urinary sphincter industry is driven by factors such as product efficacy, safety, durability, and affordability. To maintain their market position, companies also focus on strategic collaborations, mergers and acquisitions, and new product launches. Moreover, the artificial urinary sphincter business offers opportunities for new entrants with innovative technologies and approaches to challenge the established players and capture market share.
Key Players Operating in the Global Market
Latest Innovations:
| Company | ZSI |
|---|---|
| Strategy | Surgeons at French Hospital Foch Praise ZSI 100 D4 Penile Implant for Smooth Metoidioplasty Procedure |
| Details | ZSI reported that a metoidioplasty with penile implant ZSI 100 D4 was carried out by Drs. Madec and Vidart in the French hospital Foch in May 2021. Both surgeons are really happy with the implants, and the procedure went smoothly. |
| Company | Boston Scientific Corporation |
|---|---|
| Strategy | Boston Scientific's Strategic Move: Acquisition of Majority Stake in M.I.Tech Co., Ltd. |
| Details | The majority of M.I.Tech Co., Ltd., a publicly traded Korean manufacturer, and distributor of medical devices for endoscopic and urologic procedures, might be acquired by Boston Scientific Corporation. It was revealed in June 2022. |
The current artificial urinary sphincter market size stands at US$ 459.8 million in 2023.
The artificial urinary sphincter sales potential is projected to surge at a CAGR of 5.2%, surpassing a value of US$ 760.5 million by 2033.
Rising cases of urinary incontinence and technological advancements in implantable devices are molding the artificial urinary sphincter market growth.
The artificial urinary sphincter market surged from US$ 375.3 million in 2018 to US$ 441.7 million in 2022, exhibiting a 3.3% CAGR.
Given the rising demand for surgical solutions and specialized care, hospitals exhibit promising growth in the artificial urinary sphincter market.
1. Executive Summary 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Product Life Cycle Analysis 3.5. Supply Chain Analysis 3.5.1. Supply Side Participants and their Roles 3.5.1.1. Producers 3.5.1.2. Mid-Level Participants (Traders/ Agents/ Brokers) 3.5.1.3. Wholesalers and Distributors 3.5.2. Value Added and Value Created at Node in the Supply Chain 3.5.3. List of Raw Material Suppliers 3.5.4. List of Existing and Potential Buyer’s 3.6. Investment Feasibility Matrix 3.7. Value Chain Analysis 3.7.1. Profit Margin Analysis 3.7.2. Wholesalers and Distributors 3.7.3. Retailers 3.8. PESTLE and Porter’s Analysis 3.9. Regulatory Landscape 3.9.1. By Key Regions 3.9.2. By Key Countries 3.10. Regional Parent Market Outlook 3.11. Production and Consumption Statistics 3.12. Import and Export Statistics 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) & Volume (Units) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) & Volume (Units) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Type 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Type, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Type, 2023 to 2033 5.3.1. InVance Male Suburethral Sling 5.3.2. AdVance Male Suburethral Sling 5.3.3. Virtue Male Sling 5.3.4. AMS 800 5.3.5. Others 5.4. Y-o-Y Growth Trend Analysis By Type, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Type, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By End-User 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By End-User, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By End-User, 2023 to 2033 6.3.1. Hospitals 6.3.2. Clinics 6.3.3. Academic and Research Institutes 6.4. Y-o-Y Growth Trend Analysis By End-User, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By End-User, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 7.1. Introduction 7.2. Historical Market Size Value (US$ Million) & Volume (Units) Analysis By Region, 2018 to 2022 7.3. Current Market Size Value (US$ Million) & Volume (Units) Analysis and Forecast By Region, 2023 to 2033 7.3.1. North America 7.3.2. Latin America 7.3.3. Western Europe 7.3.4. Eastern Europe 7.3.5. South Asia and Pacific 7.3.6. East Asia 7.3.7. Middle East and Africa 7.4. Market Attractiveness Analysis By Region 8. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 8.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 8.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 8.2.1. By Country 8.2.1.1. U.S. 8.2.1.2. Canada 8.2.2. By Type 8.2.3. By End-User 8.3. Market Attractiveness Analysis 8.3.1. By Country 8.3.2. By Type 8.3.3. By End-User 8.4. Key Takeaways 9. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. Brazil 9.2.1.2. Mexico 9.2.1.3. Rest of Latin America 9.2.2. By Type 9.2.3. By End-User 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Type 9.3.3. By End-User 9.4. Key Takeaways 10. Western Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Germany 10.2.1.2. U.K. 10.2.1.3. France 10.2.1.4. Spain 10.2.1.5. Italy 10.2.1.6. Rest of Western Europe 10.2.2. By Type 10.2.3. By End-User 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Type 10.3.3. By End-User 10.4. Key Takeaways 11. Eastern Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Poland 11.2.1.2. Russia 11.2.1.3. Czech Republic 11.2.1.4. Romania 11.2.1.5. Rest of Eastern Europe 11.2.2. By Type 11.2.3. By End-User 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Type 11.3.3. By End-User 11.4. Key Takeaways 12. South Asia and Pacific Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Bangladesh 12.2.1.3. Australia 12.2.1.4. New Zealand 12.2.1.5. Rest of South Asia and Pacific 12.2.2. By Type 12.2.3. By End-User 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Type 12.3.3. By End-User 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Type 13.2.3. By End-User 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Type 13.3.3. By End-User 13.4. Key Takeaways 14. Middle East and Africa Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) & Volume (Units) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) & Volume (Units) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. GCC Countries 14.2.1.2. South Africa 14.2.1.3. Israel 14.2.1.4. Rest of MEA 14.2.2. By Type 14.2.3. By End-User 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Type 14.3.3. By End-User 14.4. Key Takeaways 15. Key Countries Market Analysis 15.1. U.S. 15.1.1. Pricing Analysis 15.1.2. Market Share Analysis, 2022 15.1.2.1. By Type 15.1.2.2. By End-User 15.2. Canada 15.2.1. Pricing Analysis 15.2.2. Market Share Analysis, 2022 15.2.2.1. By Type 15.2.2.2. By End-User 15.3. Brazil 15.3.1. Pricing Analysis 15.3.2. Market Share Analysis, 2022 15.3.2.1. By Type 15.3.2.2. By End-User 15.4. Mexico 15.4.1. Pricing Analysis 15.4.2. Market Share Analysis, 2022 15.4.2.1. By Type 15.4.2.2. By End-User 15.5. Germany 15.5.1. Pricing Analysis 15.5.2. Market Share Analysis, 2022 15.5.2.1. By Type 15.5.2.2. By End-User 15.6. U.K. 15.6.1. Pricing Analysis 15.6.2. Market Share Analysis, 2022 15.6.2.1. By Type 15.6.2.2. By End-User 15.7. France 15.7.1. Pricing Analysis 15.7.2. Market Share Analysis, 2022 15.7.2.1. By Type 15.7.2.2. By End-User 15.8. Spain 15.8.1. Pricing Analysis 15.8.2. Market Share Analysis, 2022 15.8.2.1. By Type 15.8.2.2. By End-User 15.9. Italy 15.9.1. Pricing Analysis 15.9.2. Market Share Analysis, 2022 15.9.2.1. By Type 15.9.2.2. By End-User 15.10. Poland 15.10.1. Pricing Analysis 15.10.2. Market Share Analysis, 2022 15.10.2.1. By Type 15.10.2.2. By End-User 15.11. Russia 15.11.1. Pricing Analysis 15.11.2. Market Share Analysis, 2022 15.11.2.1. By Type 15.11.2.2. By End-User 15.12. Czech Republic 15.12.1. Pricing Analysis 15.12.2. Market Share Analysis, 2022 15.12.2.1. By Type 15.12.2.2. By End-User 15.13. Romania 15.13.1. Pricing Analysis 15.13.2. Market Share Analysis, 2022 15.13.2.1. By Type 15.13.2.2. By End-User 15.14. India 15.14.1. Pricing Analysis 15.14.2. Market Share Analysis, 2022 15.14.2.1. By Type 15.14.2.2. By End-User 15.15. Bangladesh 15.15.1. Pricing Analysis 15.15.2. Market Share Analysis, 2022 15.15.2.1. By Type 15.15.2.2. By End-User 15.16. Australia 15.16.1. Pricing Analysis 15.16.2. Market Share Analysis, 2022 15.16.2.1. By Type 15.16.2.2. By End-User 15.17. New Zealand 15.17.1. Pricing Analysis 15.17.2. Market Share Analysis, 2022 15.17.2.1. By Type 15.17.2.2. By End-User 15.18. China 15.18.1. Pricing Analysis 15.18.2. Market Share Analysis, 2022 15.18.2.1. By Type 15.18.2.2. By End-User 15.19. Japan 15.19.1. Pricing Analysis 15.19.2. Market Share Analysis, 2022 15.19.2.1. By Type 15.19.2.2. By End-User 15.20. South Korea 15.20.1. Pricing Analysis 15.20.2. Market Share Analysis, 2022 15.20.2.1. By Type 15.20.2.2. By End-User 15.21. GCC Countries 15.21.1. Pricing Analysis 15.21.2. Market Share Analysis, 2022 15.21.2.1. By Type 15.21.2.2. By End-User 15.22. South Africa 15.22.1. Pricing Analysis 15.22.2. Market Share Analysis, 2022 15.22.2.1. By Type 15.22.2.2. By End-User 15.23. Israel 15.23.1. Pricing Analysis 15.23.2. Market Share Analysis, 2022 15.23.2.1. By Type 15.23.2.2. By End-User 16. Market Structure Analysis 16.1. Competition Dashboard 16.2. Competition Benchmarking 16.3. Market Share Analysis of Top Players 16.3.1. By Regional 16.3.2. By Type 16.3.3. By End-User 17. Competition Analysis 17.1. Competition Deep Dive 17.1.1. Boston Scientific Corporation 17.1.1.1. Overview 17.1.1.2. Product Portfolio 17.1.1.3. Profitability by Market Segments 17.1.1.4. Sales Footprint 17.1.1.5. Strategy Overview 17.1.1.5.1. Marketing Strategy 17.1.1.5.2. Product Strategy 17.1.1.5.3. Channel Strategy 17.1.2. RBM - Reinhard Becker Medizinprodukte 17.1.2.1. Overview 17.1.2.2. Product Portfolio 17.1.2.3. Profitability by Market Segments 17.1.2.4. Sales Footprint 17.1.2.5. Strategy Overview 17.1.2.5.1. Marketing Strategy 17.1.2.5.2. Product Strategy 17.1.2.5.3. Channel Strategy 17.1.3. ZSI 17.1.3.1. Overview 17.1.3.2. Product Portfolio 17.1.3.3. Profitability by Market Segments 17.1.3.4. Sales Footprint 17.1.3.5. Strategy Overview 17.1.3.5.1. Marketing Strategy 17.1.3.5.2. Product Strategy 17.1.3.5.3. Channel Strategy 17.1.4. Zephyr Surgical Implants 17.1.4.1. Overview 17.1.4.2. Product Portfolio 17.1.4.3. Profitability by Market Segments 17.1.4.4. Sales Footprint 17.1.4.5. Strategy Overview 17.1.4.5.1. Marketing Strategy 17.1.4.5.2. Product Strategy 17.1.4.5.3. Channel Strategy 17.1.5. Silimed Medical Devices 17.1.5.1. Overview 17.1.5.2. Product Portfolio 17.1.5.3. Profitability by Market Segments 17.1.5.4. Sales Footprint 17.1.5.5. Strategy Overview 17.1.5.5.1. Marketing Strategy 17.1.5.5.2. Product Strategy 17.1.5.5.3. Channel Strategy 17.1.6. Albyn Medical 17.1.6.1. Overview 17.1.6.2. Product Portfolio 17.1.6.3. Profitability by Market Segments 17.1.6.4. Sales Footprint 17.1.6.5. Strategy Overview 17.1.6.5.1. Marketing Strategy 17.1.6.5.2. Product Strategy 17.1.6.5.3. Channel Strategy 17.1.7. GT Urological LLC 17.1.7.1. Overview 17.1.7.2. Product Portfolio 17.1.7.3. Profitability by Market Segments 17.1.7.4. Sales Footprint 17.1.7.5. Strategy Overview 17.1.7.5.1. Marketing Strategy 17.1.7.5.2. Product Strategy 17.1.7.5.3. Channel Strategy 17.1.8. Promedon 17.1.8.1. Overview 17.1.8.2. Product Portfolio 17.1.8.3. Profitability by Market Segments 17.1.8.4. Sales Footprint 17.1.8.5. Strategy Overview 17.1.8.5.1. Marketing Strategy 17.1.8.5.2. Product Strategy 17.1.8.5.3. Channel Strategy 17.1.9. UroMems Inc. 17.1.9.1. Overview 17.1.9.2. Product Portfolio 17.1.9.3. Profitability by Market Segments 17.1.9.4. Sales Footprint 17.1.9.5. Strategy Overview 17.1.9.5.1. Marketing Strategy 17.1.9.5.2. Product Strategy 17.1.9.5.3. Channel Strategy 17.1.10. Uromedica Inc. 17.1.10.1. Overview 17.1.10.2. Product Portfolio 17.1.10.3. Profitability by Market Segments 17.1.10.4. Sales Footprint 17.1.10.5. Strategy Overview 17.1.10.5.1. Marketing Strategy 17.1.10.5.2. Product Strategy 17.1.10.5.3. Channel Strategy 17.1.11. My powers Medical 17.1.11.1. Overview 17.1.11.2. Product Portfolio 17.1.11.3. Profitability by Market Segments 17.1.11.4. Sales Footprint 17.1.11.5. Strategy Overview 17.1.11.5.1. Marketing Strategy 17.1.11.5.2. Product Strategy 17.1.11.5.3. Channel Strategy 17.1.12. CooperSurgical Inc. 17.1.12.1. Overview 17.1.12.2. Product Portfolio 17.1.12.3. Profitability by Market Segments 17.1.12.4. Sales Footprint 17.1.12.5. Strategy Overview 17.1.12.5.1. Marketing Strategy 17.1.12.5.2. Product Strategy 17.1.12.5.3. Channel Strategy 17.1.13. Laborie Medical Technologies Inc. 17.1.13.1. Overview 17.1.13.2. Product Portfolio 17.1.13.3. Profitability by Market Segments 17.1.13.4. Sales Footprint 17.1.13.5. Strategy Overview 17.1.13.5.1. Marketing Strategy 17.1.13.5.2. Product Strategy 17.1.13.5.3. Channel Strategy 18. Assumptions & Acronyms Used 19. Research Methodology
Explore Healthcare Insights
View Reports
Artificial Urinary Sphincter Market
